Janus Henderson Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $595K | Hold |
34,412
| – | – | ﹤0.01% | 1855 |
|
|
2025
Q1 | $836K | Hold |
34,412
| – | – | ﹤0.01% | 1714 |
|
|
2024
Q4 | $1.1M | Hold |
34,412
| – | – | ﹤0.01% | 1642 |
|
|
2024
Q3 | $992K | Hold |
34,412
| – | – | ﹤0.01% | 1670 |
|
|
2024
Q2 | $1.32M | Sell |
34,412
-527
| -2% | -$20.2K | ﹤0.01% | 1470 |
|
|
2024
Q1 | $2.05M | Sell |
34,939
-2,978
| -8% | -$175K | ﹤0.01% | 1283 |
|
|
2023
Q4 | $2.27M | Sell |
37,917
-74
| -0.2% | -$4.43K | ﹤0.01% | 1176 |
|
|
2023
Q3 | $1.44M | Sell |
37,991
-1,738,914
| -98% | -$66.1M | ﹤0.01% | 1356 |
|
|
2023
Q2 | $162M | Sell |
1,776,905
-2,904,577
| -62% | -$265M | 0.1% | 193 |
|
|
2023
Q1 | $309M | Buy |
4,681,482
+693,737
| +17% | +$45.8M | 0.2% | 120 |
|
|
2022
Q4 | $206M | Buy |
3,987,745
+3,959,473
| +14,005% | +$205M | 0.15% | 155 |
|
|
2022
Q3 | $1.93M | Buy |
28,272
+12,178
| +76% | +$830K | ﹤0.01% | 1319 |
|
|
2022
Q2 | $728K | Buy |
16,094
+122
| +0.8% | +$5.52K | ﹤0.01% | 1533 |
|
|
2022
Q1 | $811K | Buy |
15,972
+65
| +0.4% | +$3.3K | ﹤0.01% | 1613 |
|
|
2021
Q4 | $753K | Buy |
15,907
+9,814
| +161% | +$465K | ﹤0.01% | 1645 |
|
|
2021
Q3 | $201K | Buy |
+6,093
| New | +$201K | ﹤0.01% | 2077 |
|